Skip to main content

Animations

MJFF Publications

4131 - 4140 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2023
  • 2022
  • 2025
  • 2019
  • 2019
  • 2019
  • 2019
  • 2017
  • 2018
  • Summary Details
    OPEN
    Title: Alzheimer's disease‐associated CD83(+) microglia are linked with increased immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brain
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.14401
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Temporal landscape of mitochondrial proteostasis governed by the UPR mt
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adh8228
    Citation Count: 19
  • Summary Details
    OPEN
    Title: A step forward for LRRK2 inhibitors in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abq7374
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Structure–Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1H-indoles as Tauopathy Positron Emission Tomography Radiotracers
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.4c02988
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2019.08.006
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cortex.2019.01.016
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity
    Journal Name: Molecular Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.molmet.2019.02.005
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Quantitative magnetization transfer imaging of the human locus coeruleus
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2019.06.049
    Citation Count: 46
  • Summary Details
    OPEN
    Title: The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.12.012
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Genetic analysis of neurodegenerative diseases in a pathology cohort
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.11.007
    Citation Count: 38
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.